Search research articles
Contact Us
Filters
Showing results (211-220 of 401) with videos related to
Page
of 41
Sort By:
Platelets
|
June 17, 2020
Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention
Wael Sumaya, William A E Parker, Heather M Judge, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 25, 2019
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial
Frederic Kontny, Thomas Andersen, Thor Ueland, et al.
European Heart Journal
|
August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes
Robert F Storey, Richard C Becker, Robert A Harrington, et al.
European Heart Journal
|
March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding
Davide Cao, Nicolas Amabile, Mauro Chiarito, et al.
Haematologica
|
May 2, 2020
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
Rhodri J King, Katharina Schuett, Christian Tiede, et al.
Clinical Chemistry
|
December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study
Åxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
American Heart Journal
|
September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Jan H Cornel, Richard C Becker, Shaun G Goodman, et al.
Journal of the American Heart Association
|
March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
Francesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Circulation
|
June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Journal of the American College of Cardiology
|
May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy
Benjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.
Page
of 41
Search research articles
Search
Showing results (211-220 of 401) with videos related to
Sort By:
Page
of 41
Platelets
|
June 17, 2020
Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention
Wael Sumaya, William A E Parker, Heather M Judge, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 25, 2019
Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial
Frederic Kontny, Thomas Andersen, Thor Ueland, et al.
European Heart Journal
|
August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes
Robert F Storey, Richard C Becker, Robert A Harrington, et al.
European Heart Journal
|
March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding
Davide Cao, Nicolas Amabile, Mauro Chiarito, et al.
Haematologica
|
May 2, 2020
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
Rhodri J King, Katharina Schuett, Christian Tiede, et al.
Clinical Chemistry
|
December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study
Åxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
American Heart Journal
|
September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Jan H Cornel, Richard C Becker, Shaun G Goodman, et al.
Journal of the American Heart Association
|
March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
Francesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Circulation
|
June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Journal of the American College of Cardiology
|
May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy
Benjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.
Page
of 41